{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T11:07:06Z","timestamp":1772276826292,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Homozygous familial hypercholesterolaemia (HoFH) increases risk of premature cardiovascular events and cardiac death.\u00a0In severe cases of HoFH, clinical signs and symptoms cannot be controlled well by non-surgical treatments, liver transplantation (LT) currently represents the viable option.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>To assess the clinical efficacy, prognosis, and optimal timing of LT for HoFH, a retrospective analysis was conducted on the preoperative, surgical conditions, and postoperative follow-up of children\u00a0who received an LT for HoFH at the Beijing Friendship Hospital over the period from December 2014 to August 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Xanthoma and decreased activity tolerance were the primary clinical manifestations in the 7 HoFH children initially assessed (one child died suddenly prior to surgery due to cardiac arrest). Accompanying these symptoms were increased blood total cholesterol (TC) and low density lipoprotein (LDL) levels, along with severe cardiovascular diseases.\u00a0HoFH was confirmed in all cases by genetic and biochemical assays. Initial treatments administered to these patients consisted of low-fat diets and lipid-lowering drugs with poor outcomes. Accordingly, all 6 patients received orthotopic liver transplantations (OLT), with the result that significant postoperative reductions were observed in levels of TC and LDL. The median follow-up of these six cases was 37.41\u00a0months (range: 19.40\u201394.10\u00a0months). Regular postoperative follow-ups revealed that all survived and showed significant improvements in their clinical symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>So far, LT is the only way to heal HoFH. LT before the appearance of obvious cardiovascular atherosclerotic lesions can significantly improve the quality of life and prognosis of patients. At the same time, the blood cholesterol level of patients should be continuously monitored after LT to further control the progression of vascular complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-024-03443-z","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:51:53Z","timestamp":1736920313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Liver transplantation for homozygous familial hypercholesterolemia: a retrospective analysis from Chinese experience"],"prefix":"10.1186","volume":"20","author":[{"given":"Hao-Su","family":"Zhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Gui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Le","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En-Hui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1101-7994","authenticated-orcid":false,"given":"Li-Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"32","key":"3443_CR1","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","volume":"35","author":"M Cuchel","year":"2014","unstructured":"Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the European atherosclerosis society. Eur Heart J. 2014;35(32):2146\u201357.","journal-title":"Eur Heart J"},{"issue":"10","key":"3443_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrcardio.2015.92","volume":"12","author":"\u017d Reiner","year":"2015","unstructured":"Reiner \u017d. Management of patients with familial hypercholesterolaemia. Nat Rev Cardiol. 2015;12(10):565\u201375.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"3443_CR3","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1111\/j.1399-3046.2010.01383.x","volume":"15","author":"A Maiorana","year":"2011","unstructured":"Maiorana A, Nobili V, Calandra S, Francalanci P, Bernabei S, El HM, et al. Preemptive liver transplantation in a child with familial hypercholesterolemia. Pediatr Transplant. 2011;15(2):E25\u20139.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"3443_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13023-022-02233-9","volume":"17","author":"ZG Zeng","year":"2022","unstructured":"Zeng ZG, Zhou GP, Wei L, Qu W, Liu Y, Tan YL, et al. Therapeutic potential of living donor liver transplantation from heterozygous carrier donors in children with propionic acidemia. Orphanet J Rare Dis. 2022;17(1):62.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"3443_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.21037\/hbsn.2019.03.04","volume":"8","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG, et al. Perioperative characteristics and management of liver transplantation for isolated methylmalonic acidemia-the largest experience in China. Hepatobiliary Surg Nutr. 2019;8(5):470\u20139.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"1","key":"3443_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2015.03.064","volume":"565","author":"FA Al-Allaf","year":"2015","unstructured":"Al-Allaf FA, Athar M, Abduljaleel Z, Taher MM, Khan W, Ba-Hammam FA, et al. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease. Gene. 2015;565(1):76\u201384.","journal-title":"Gene"},{"issue":"9","key":"3443_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","volume":"36","author":"B Sjouke","year":"2015","unstructured":"Sjouke B, Kusters DM, Kindt I, Besseling J, Defesche JC, Sijbrands EJ, et al. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome. Eur Heart J. 2015;36(9):560\u20135.","journal-title":"Eur Heart J"},{"issue":"1","key":"3443_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.gene.2013.03.034","volume":"521","author":"M Soufi","year":"2013","unstructured":"Soufi M, Rust S, Walter M, Schaefer JR. A combined LDL receptor\/LDL receptor adaptor protein 1 mutation as the cause for severe familial hypercholesterolemia. Gene. 2013;521(1):200\u20133.","journal-title":"Gene"},{"key":"3443_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2019.03.016","volume":"143","author":"S Hajighasemi","year":"2019","unstructured":"Hajighasemi S, Mahdavi GA, Bianconi V, Pirro M, Banach M, Ahmadi TH, et al. A review of gene- and cell-based therapies for familial hypercholesterolemia. Pharmacol Res. 2019;143:119\u201332.","journal-title":"Pharmacol Res"},{"issue":"4","key":"3443_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jacl.2016.04.009","volume":"10","author":"JM Foody","year":"2016","unstructured":"Foody JM, Vishwanath R. Familial hypercholesterolemia\/autosomal dominant hypercholesterolemia: molecular defects, the LDL-C continuum, and gradients of phenotypic severity. J Clin Lipidol. 2016;10(4):970\u201386.","journal-title":"J Clin Lipidol"},{"issue":"5","key":"3443_CR11","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.transproceed.2005.03.037","volume":"37","author":"BJ Alkofer","year":"2005","unstructured":"Alkofer BJ, Chiche L, Khayat A, Deshayes JP, Lepage A, Saloux E, et al. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Transplant Proc. 2005;37(5):2250\u20132.","journal-title":"Transplant Proc"},{"issue":"2","key":"3443_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5551\/jat.14.94","volume":"14","author":"N Kawagishi","year":"2007","unstructured":"Kawagishi N, Satoh K, Akamatsu Y, Sekiguchi S, Ishigaki Y, Oikawa S, et al. Long-term outcome after living donor liver transplantation for two cases of homozygous familial hypercholesterolemia from a heterozygous donor. J Atheroscler Thromb. 2007;14(2):94\u20138.","journal-title":"J Atheroscler Thromb"},{"issue":"2","key":"3443_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1399-0012.2007.00764.x","volume":"22","author":"HH Schmidt","year":"2008","unstructured":"Schmidt HH, Tietge UJ, Buettner J, Barg-Hock H, Offner G, Schweitzer S, et al. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation. Clin Transplant. 2008;22(2):180\u20134.","journal-title":"Clin Transplant"},{"key":"3443_CR14","first-page":"154908","volume":"2011","author":"CH Palacio","year":"2011","unstructured":"Palacio CH, Harring TR, Nguyen NT, Goss JA, O\u2019Mahony CA. Homozygous familial hypercholesterolemia: case series and review of the literature. Case Rep Transplant. 2011;2011:154908.","journal-title":"Case Rep Transplant"},{"issue":"3","key":"3443_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/chd.12352","volume":"11","author":"D Char","year":"2016","unstructured":"Char D, Ramamoorthy C, Wise-Faberowski L. Cognitive dysfunction in children with heart disease: the role of anesthesia and sedation. Congenit Heart Dis. 2016;11(3):221\u20139.","journal-title":"Congenit Heart Dis"},{"issue":"5","key":"3443_CR16","doi-asserted-by":"publisher","first-page":"e20160740","DOI":"10.1542\/peds.2016-0740","volume":"138","author":"M Greco","year":"2016","unstructured":"Greco M, Robinson JD, Eltayeb O, Benuck I. Progressive aortic stenosis in homozygous familial hypercholesterolemia after liver transplant. Pediatrics. 2016;138(5):e20160740.","journal-title":"Pediatrics"},{"issue":"4","key":"3443_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.amjcard.2016.05.042","volume":"118","author":"M Martinez","year":"2016","unstructured":"Martinez M, Brodlie S, Griesemer A, Kato T, Harren P, Gordon B, et al. Effects of liver transplantation on lipids and cardiovascular disease in children with homozygous familial hypercholesterolemia. Am J Cardiol. 2016;118(4):504\u201310.","journal-title":"Am J Cardiol"},{"issue":"6","key":"3443_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jacl.2019.09.007","volume":"13","author":"CE Cephus","year":"2019","unstructured":"Cephus CE, Qureshi AM, Sexson TS, Alam M, Moodie DS. Coronary artery disease in a child with homozygous familial hypercholesterolemia: regression after liver transplantation. J Clin Lipidol. 2019;13(6):880\u20136.","journal-title":"J Clin Lipidol"},{"key":"3443_CR19","doi-asserted-by":"publisher","first-page":"567895","DOI":"10.3389\/fped.2020.567895","volume":"8","author":"M Mlinaric","year":"2020","unstructured":"Mlinaric M, Bratanic N, Dragos V, Skarlovnik A, Cevc M, Battelino T, et al. Case report: liver transplantation in homozygous familial hypercholesterolemia (HoFH)-long-term follow-up of a patient and literature review. Front Pediatr. 2020;8:567895.","journal-title":"Front Pediatr"},{"issue":"19","key":"3443_CR20","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.jacc.2014.01.060","volume":"63","author":"AD Sniderman","year":"2014","unstructured":"Sniderman AD, Tsimikas S, Fazio S. The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies. J Am Coll Cardiol. 2014;63(19):1935\u201347.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3443_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jacl.2018.12.003","volume":"13","author":"IK Luirink","year":"2019","unstructured":"Luirink IK, Braamskamp M, Wiegman A, Hartgers ML, Sjouke B, Defesche JC, et al. The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study. J Clin Lipidol. 2019;13(2):272\u20138.","journal-title":"J Clin Lipidol"},{"issue":"6","key":"3443_CR22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.jacl.2016.09.003","volume":"10","author":"B Sjouke","year":"2016","unstructured":"Sjouke B, Defesche JC, Hartgers ML, Wiegman A, Roeters VLJ, Kastelein JJ, et al. Double-heterozygous autosomal dominant hypercholesterolemia: clinical characterization of an underreported disease. J Clin Lipidol. 2016;10(6):1462\u20139.","journal-title":"J Clin Lipidol"},{"issue":"4","key":"3443_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/HCO.0b013e3283605fa2","volume":"28","author":"AS Wierzbicki","year":"2013","unstructured":"Wierzbicki AS, Viljoen A, Hardman TC, Mikhailidis DP. New therapies to reduce low-density lipoprotein cholesterol. Curr Opin Cardiol. 2013;28(4):452\u20137.","journal-title":"Curr Opin Cardiol"},{"key":"3443_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1749-6632.1991.tb43737.x","volume":"623","author":"JM Hoeg","year":"1991","unstructured":"Hoeg JM. Pharmacologic and surgical treatment of dyslipidemic children and adolescents. Ann N Y Acad Sci. 1991;623:275\u201384.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"3443_CR25","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1053\/jpsu.2000.0350630","volume":"35","author":"M Lopez-Santamaria","year":"2000","unstructured":"Lopez-Santamaria M, Migliazza L, Gamez M, Murcia J, Diaz-Gonzalez M, Camarena C, et al. Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass. J Pediatr Surg. 2000;35(4):630\u20133.","journal-title":"J Pediatr Surg"},{"issue":"2","key":"3443_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5551\/jat.RV17029","volume":"26","author":"Y Ishigaki","year":"2019","unstructured":"Ishigaki Y, Kawagishi N, Hasegawa Y, Sawada S, Katagiri H, Satomi S, et al. Liver transplantation for homozygous familial hypercholesterolemia. J Atheroscler Thromb. 2019;26(2):121\u20137.","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"3443_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1432-2277.2003.tb00299.x","volume":"16","author":"Y Shirahata","year":"2003","unstructured":"Shirahata Y, Ohkohchi N, Kawagishi N, Syouji M, Tsukamoto S, Sekiguchi S, et al. Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia. Transpl Int. 2003;16(4):276\u20139.","journal-title":"Transpl Int"},{"issue":"12","key":"3443_CR28","doi-asserted-by":"publisher","first-page":"e13730","DOI":"10.1111\/ctr.13730","volume":"33","author":"KN Gulsoy","year":"2019","unstructured":"Gulsoy KN, Kirnap M, Bascil TN, Moray G, Haberal M. The curative treatment of familial hypercholesterolemia: liver transplantation. Clin Transplant. 2019;33(12):e13730.","journal-title":"Clin Transplant"},{"issue":"6","key":"3443_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/petr.12562","volume":"19","author":"M Mansoorian","year":"2015","unstructured":"Mansoorian M, Kazemi K, Nikeghbalian S, Shamsaeefar A, Mokhtari M, Dehghani SM, et al. Liver transplantation as a definitive treatment for familial hypercholesterolemia: a series of 36 cases. Pediatr Transplant. 2015;19(6):605\u201311.","journal-title":"Pediatr Transplant"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03443-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03443-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03443-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:51:55Z","timestamp":1736920315000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03443-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3443"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03443-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2708308\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"18 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Medical Ethics Committee of Beijing Friendship Hospital, Capital Medical University (ID: 2020-P2-094-01). Informed consent was obtained from the parents of all patients included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the parents of all patients included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}